Keywords: fda, clears, csl, behring, rhophylac, itp, food

FDA clears CSL Behring's Rhophylac for ITP

Article | 09 April 2007

Print This

The US Food and Drug Administration has granted marketing approval for an additional indication for CSL Behring' Rhophylac Rh(0)(D) ( ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in